Schonfeld Strategic Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
15,528
-19,166
-55% -$2.24M 0.01% 1071
2026
Q1
$4.17M Sell
34,694
-51,961
-60% -$6M 0.03% 550
2025
Q4
$9.12M Sell
86,655
-341,110
-80% -$32M 0.04% 367
2025
Q3
$35.9M Buy
427,765
+377,266
+747% +$31.1M 0.2% 73
2025
Q2
$4M Sell
50,499
-516,105
-91% -$41M 0.03% 644
2025
Q1
$50.9M Buy
566,604
+124,962
+28% +$11.7M 0.31% 34
2024
Q4
$43.9M Buy
441,642
+412,209
+1,400% +$42.5M 0.26% 49
2024
Q3
$3.34M Sell
29,433
-103,235
-78% -$12.3M 0.02% 681
2024
Q2
$16.4M Buy
132,668
+66,180
+100% +$8.52M 0.11% 211
2024
Q1
$8.77M Buy
66,488
+60,806
+1,070% +$7.49M 0.06% 422
2023
Q4
$619K Sell
5,682
-68,868
-92% -$7.15M ﹤0.01% 1205
2023
Q3
$7.67M Sell
74,550
-22,903
-24% -$2.47M 0.06% 425
2023
Q2
$11.2M Buy
97,453
+22,740
+30% +$2.58M 0.1% 317
2023
Q1
$7.95M Buy
74,713
+39,614
+113% +$4.28M 0.08% 340
2022
Q4
$3.89M Sell
35,099
-33,007
-48% -$3.37M 0.03% 559
2022
Q3
$5.87M Buy
68,106
+19,946
+41% +$1.78M 0.05% 479
2022
Q2
$4.39M Sell
48,160
-36,542
-43% -$3.24M 0.04% 509
2022
Q1
$6.95M Buy
84,702
+79,302
+1,469% +$6.25M 0.06% 343
2021
Q4
$414K Sell
5,400
-70,261
-93% -$5.6M ﹤0.01% 1360
2021
Q3
$5.68M Buy
+75,661
New +$5.75M 0.06% 397
2021
Q1
Sell
-145,196
Closed -$11.3M 2017
2020
Q4
$11.3M Buy
145,196
+37,279
+35% +$2.85M 0.15% 184
2020
Q3
$8.54M Buy
107,917
+51,169
+90% +$4.01M 0.16% 178
2020
Q2
$4.19M Buy
56,748
+19,962
+54% +$1.5M 0.11% 264
2020
Q1
$2.7M Sell
36,786
-88,079
-71% -$6.92M 0.17% 140
2019
Q4
$10.8M Buy
124,865
+4,188
+3% +$344K 0.26% 100
2019
Q3
$9.69M Sell
120,677
-34,893
-22% -$2.8M 0.28% 102
2019
Q2
$12.4M Sell
155,570
-29,297
-16% -$2.24M 0.44% 54
2019
Q1
$14.7M Buy
184,867
+35,527
+24% +$2.66M 0.51% 36
2018
Q4
$10.9M Sell
149,340
-149,087
-50% -$10.5M 0.42% 52
2018
Q3
$20.2M Buy
298,427
+14,347
+5% +$914K 0.9% 11
2018
Q2
$16.5M Buy
284,080
+268,217
+1,691% +$15.1M 0.89% 6
2018
Q1
$825K Buy
+15,863
New +$857K 0.06% 370
2017
Q4
Sell
-206,695
Closed -$12.6M 827
2017
Q3
$12.6M Buy
206,695
+6,152
+3% +$373K 1.15% 5
2017
Q2
$12.3M Buy
+200,543
New +$12.2M 1.26% 5
2017
Q1
Sell
-36,002
Closed -$2.02M 684
2016
Q4
$2.02M Buy
+36,002
New +$2.11M 0.26% 112
2016
Q3
Sell
-24,793
Closed -$1.36M 494
2016
Q2
$1.36M Buy
+24,793
New +$1.32M 0.31% 87

Other funds holding MRK

Schonfeld Strategic Advisors's MRK Position: Q2 2026 in Review

Schonfeld Strategic Advisors reduced its Merck (MRK) stake by 55% in Q2 2026, selling an estimated $2.24M and leaving 15,528 shares worth $2M. The position accounts for 0.01% of the portfolio, ranked #1071.

Schonfeld Strategic Advisors first reported a position in MRK in Q2 2016 and has held it in 36 quarters since. The position peaked at $50.9M in Q1 2025. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Schonfeld Strategic Advisors held 15,528 shares of Merck worth $2M as of Q2 2026.
  • Schonfeld Strategic Advisors sold 19,166 Merck shares in Q2 2026, an estimated $2.24M.
  • Merck made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1071 holding.
  • Schonfeld Strategic Advisors first reported a position in Merck in Q2 2016 and has held it in 36 quarters since.
  • Schonfeld Strategic Advisors's Merck position peaked at $50.9M in Q1 2025.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.